Sympatient
PrivateLast Round
Series A
Sep 29, 2022
Total Funding Raised
$9.07M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sympatient operates in Healthcare & Life Sciences and is based in Hamburg. Its latest recorded funding round was a Series A round in September 2022.
Sympatient is a health technology company that develops PsyOS®, a software-enabled care infrastructure designed to make psychotherapy more accessible, scalable, and efficient within regulated healthcare systems.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Medical Devices, AR/VR Experiences, Patient Engagement
Business Model
B2B2C
Customer Profile
Government Contracts, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sympatient Comparables
Compare Sympatient with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HelloBetter | 87% | |
| Mindable Health | 86% | |
| MEDICE Arzneimittel Pütter | 85% |
For institutional investors. Book with your work email.
Sympatient Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 29, 2022 | ||||
| Seed | May 28, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sympatient Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Seed, Series A |
| IFB Hamburg | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 189% MoM, reaching 12.2K.
- Jul 25, 2026
Monthly visitors grew 124% MoM, reaching 4.9K.
For institutional investors. Book with your work email.
Sympatient Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sympatient's valuation, stock price, and market status.
Is Sympatient a public or private company?
Sympatient is a private company.
What is the current stock price of Sympatient?
Sympatient is a private company, so its shares have no public market price. Caplight tracks Sympatient's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sympatient worth (valuation)?
Valuation information for Sympatient is not publicly available.
Can I buy Sympatient stock?
Sympatient shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sympatient's last funding round?
Sympatient's most recent funding round was Series A on September 29, 2022.
Who are the main investors in Sympatient?
Key investors in Sympatient include Verve Ventures.
Will Sympatient IPO soon?
No public IPO plans have been announced for Sympatient.
How can I track Sympatient secondary market activity?
Caplight tracks bids, offers, and trades in Sympatient's shares on secondary markets.